Understanding Type 2 Diabetes and its Variations in South Asians
Molecular Prediction, Disease Progression, and Type 2 Diabetes (T2D) Phenotypes in South Asians
This study is looking at how Type 2 Diabetes and prediabetes show up differently in South Asian people, with the goal of finding out what makes these differences happen so that treatments can be better tailored for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11071323 on NIH RePORTER |
What this research studies
This research investigates the different forms of Type 2 Diabetes (T2D) and prediabetes specifically in South Asian populations, who are at a higher risk for these conditions. It aims to uncover the biological and genetic factors that contribute to the unique manifestations of T2D in this group, including how these factors influence disease progression and treatment responses. By analyzing a large cohort of individuals, the study seeks to identify distinct phenotypes of T2D and their associated risks, which could lead to more personalized treatment strategies. Participants may provide biological samples to help in understanding the molecular mechanisms behind these diabetes phenotypes.
Who could benefit from this research
Good fit: Ideal candidates for this research include South Asian adults aged 21 and older who are at risk for or have been diagnosed with Type 2 Diabetes or prediabetes.
Not a fit: Patients who are not of South Asian descent or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for Type 2 Diabetes tailored specifically for South Asian individuals.
How similar studies have performed: Previous research has shown success in identifying distinct diabetes phenotypes in other populations, but this study focuses on a relatively underexplored demographic, making it a novel approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Narayan, Kabayam M Venkat — Emory University
- Study coordinator: Narayan, Kabayam M Venkat
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.